Valhi (VHI) News & Sentiment

Dallas, Texas, March 06, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.8 million, or $.80 per share, in the fourth quarter of 2024 compared to net income of $4.9 million, or $.17 per share, in the fourth quarter of 2023. For the full year of 2024, Valhi reported net income attributable to Valhi stockholders of $108.0 million, or $3.79 per share, compared to a net loss of $9.9 million, or $.35 per share, for the full year of 2023. Net income attributable to Valhi stockholders increased in the fourth quarter of 2024 as compared to the fourth quarter of 2023 primarily due to higher operating results from the Chemicals Segment and aggregate income of $31.4 million ($20.6 million, or $.72 per share, net of tax and noncontrolling interest) related to the settlement of a liability for an environmental remediation site in 2024 partially offset by an increase in the Company's tax expense resulting from (i) final tax regulations on the Chemicals Segment's treatment of certain currency translation gains and losses, which resulted in a non-cash deferred income tax expense of $16.5 million ($10.9 million, or $.38 per share, net of tax and noncontrolling interest) and (ii) the recognition of a deferred income tax asset valuation allowance related to the Chemicals Segment's Belgian net deferred tax assets, which resulted in a non-cash deferred income tax expense of $8.2 million ($5.4 million, or $.19 per share, net of tax and noncontrolling interest). Net income attributable to Valhi stockholders increased in the full year of 2024 as compared to the full year of 2023 primarily due to the net effects of higher operating results from the Chemicals Segment, a third quarter non-cash gain related to the Chemicals Segment acquisition of the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) discussed below, the settlement of a liability for an environmental remediation site and an increase in our tax expense, discussed above.

Toronto, Ontario--(Newsfile Corp. - January 9, 2025) - Vitalhub Corp. (TSX: VHI) (the "Company" or "VitalHub") is pleased to announce it has closed its previously announced bought deal offering pursuant to a press release dated December 17, 2024. A total of 3,165,145 common shares of VitalHub (the "Common Shares") were sold at a price of $10.90 per Common Share for total gross proceeds of approximately $34.5 million, which included the full exercise of the over-allotment option (the "Offering").

Final Short Form Prospectus Accessible on SEDAR+ Toronto, Ontario--(Newsfile Corp. - January 3, 2025) - Vitalhub Corp. (TSX: VHI) (the "Company" or "VitalHub") is pleased to announce that, in connection with its previously announced "bought deal" public financing, it has filed a final short form prospectus dated January 2, 2025 (the "Final Prospectus") to qualify the distribution of 2,752,300 common shares from the treasury of the Company (the "Common Shares") at a price of $10.90 per Common Share (the "Offering Price") and up to an additional 412,845 Common Shares at the Offering Price to be issued upon exercise of an over-allotment option, the particulars of which are further described in the Final Prospectus (the "Offering"). Closing is expected on or about January 9, 2025, and is subject to regulatory approval, including that of the Toronto Stock Exchange.

TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has amended and expanded its existing credit facilities with The Bank of Nova Scotia to further strengthen the Company's financial flexibility. Under the terms of the amendment, the Company's total committed borrowing capacity has increased to $65 million from $33 million.

Dallas, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $57.5 million, or $2.01 per share, in the third quarter of 2024 compared to a net loss of $5.8 million, or $.21 per share, in the third quarter of 2023. For the first nine months of 2024, Valhi reported net income attributable to Valhi stockholders of $85.2 million, or $2.99 per share, compared to a net loss of $14.8 million, or $.52 per share, in the first nine months of 2023. Net income attributable to Valhi stockholders increased in the third quarter and first nine months of 2024 as compared to the same periods in 2023 primarily due to higher operating results from the Chemicals Segment and a non-cash gain discussed below.

TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it will release its financial results for its third quarter 2024 ended September 30th, 2024, after market close on November 13th, 2024. The Company will subsequently hold a conference call via Zoom on November 14th, 2024, at 9:00am EST hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow.

TORONTO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Strata Health Solutions Inc. (“Strata Health”), a leading provider of patient flow solutions internationally.

Toronto, Ontario--(Newsfile Corp. - September 10, 2024) - VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the "Company" or "VitalHub") is proud to announce its inclusion in the 2024 TSX30™, the Toronto Stock Exchange's prestigious ranking of the top 30 performing stocks over the past three years. VitalHub has achieved the 26th position on this esteemed list, showcasing a remarkable 136% three-year dividend-adjusted share price performance and a 231% increase in market capitalization.

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has signed a definitive agreement (the “Definitive Agreement”) to acquire MedCurrent Corporation and its subsidiaries (“MedCurrent”), by way of a court-approved plan of arrangement under the provisions of the Business Corporations Act (Ontario) (the “Transaction”).